• Activity INFORMATION

  Overview

  In this podcast-style discussion, Dr. Mike Corvino, PharmD, and Dr. Cole Swanson, PharmD, examine management strategies for axial spondyloarthritis (axSpA), a chronic inflammatory condition that primarily affects the spine and sacroiliac joints, causing pain and stiffness. AxSpA encompasses both radiographic and non-radiographic forms, with the potential for significant impairment in daily activities and quality of life. Uncontrolled inflammation in axSpA can lead to structural damage, reduced mobility, and associated complications such as uveitis and inflammatory bowel disease. This session will equip healthcare professionals, including pharmacists and nurses, with knowledge of relevant pharmacologic therapies along with non-pharmacologic approaches like physical therapy and lifestyle management. The goal is to improve patient outcomes through individualized care plans and effective long-term disease monitoring.

  Access the original podcast here.

   

  
  

  Handouts

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Evaluate current guidelines and evidence-based treatment strategies for managing axial spondyloarthritis, including pharmacological and non-pharmacological interventions.

  Recognize effective strategies for incorporating patient-specific factors such as disease state activity, comorbidities, and patient quality of life.

  Compare and contrast the efficacy, safety profiles, and appropriate use of biologic and non-biologic therapies, lifestyle modifications, and patient monitoring in treating axial spondyloarthritis.

  Define axial spondyloarthritis (axSpA) and describe its clinical presentations, etiologies, and pathophysiology.

  Nurse

  Recognize effective strategies for incorporating patient-specific factors such as disease state activity, comorbidities, and patient quality of life.

  Evaluate current guidelines and evidence-based treatment strategies for managing axial spondyloarthritis, including pharmacological and non-pharmacological interventions.

  Define axial spondyloarthritis (axSpA) and describe its clinical presentations, etiologies, and pathophysiology.

  Compare and contrast the efficacy, safety profiles, and appropriate use of biologic and non-biologic therapies, lifestyle modifications, and patient monitoring in treating axial spondyloarthritis.

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1260798

  Universal Activity Number

  Pharmacist 0798-0000-24-252-H01-P
  Nurse 0798-0000-24-252-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Coleman  Swanson, PharmD, CDCES Clinical Pharmacist - Neurology, MUSC Specialty Pharmacy Department

  Michael  Corvino, PharmD, BCPS, BCACP, CDCES Clinical Pharmacist, Fetter Health Care Network

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).